Efficacy of canagliflozin (CANA) versus dipeptidyl peptidase-4 inhibitors (DPP-4i) in patients with T2DM: Results from RCTs and Real-World (RW) study. (October 2016) - Canovatchel, William; Thayer, Sarah; Chow, Wing; Qiu, Rong; Davies, Michael; Fegade, Mayuresh